VOLUME 8, ISSUE 1 - Spring 2014
Global Substance Abuse Trends: Connecting the Science and the Policy
Included in this edition of The Journal of Global Drug Policy and Practice are the results of a study entitled, “Characteristics and Evidences of Effectiveness of a Locally Developed Prevention Framework: The Community Prevention Education Continuum.” This paper provides a detailed analysis of an on-going Canadian program called Community Prevention Education Continuum (CPEC) that utilizes multiple, concurrent, evidence-based approaches in youth substance abuse prevention and which follows best-practice processes in community action. Starting out as a partnership between the Royal Canadian Mounted Police and regional addictions service providers, CPEC evolved into a robust initiative that focuses on extraordinary community partnerships and mobilization. The results of the study showed a significant and long-lasting reduction in youth substance use.
We are also pleased to offer a reprint from Pain Medicine News entitled “Marijuana Usage in Chronic Pain Patients: Driving and Work Guidelines for Clinicians.” This paper focuses on the use of marijuana in patients with chronic pain. Bypassing a philosophical bias as to whether marijuana is good or bad, it evaluates safety and risk versus the benefit of the drug.
Our commentary, “Determining Medicine through Science: Clinical Approach to Cannabidiol Studies Results in Positive Outcomes for Patients,” provides an overview on the current issues in the U.S. surrounding the study and use of cannabidiol (CBD), the non-psychoactive compound found in Cannabis sativa L. that has shown promise in treating severe forms of childhood epilepsy. It explores the differences between the non-regulated and untested version of this compound grown in Colorado by the Stanley Brothers called "Charlotte's Web" versus the GW Pharmaceutical version called Epidiolex(TM) which has just received orphan drug status from the Food and Drug Administration and is available in certain clinical settings.